Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| SEGA | 2 | 3 | 0,00 % | ||
| EUGLENA | 2 | 2 | +0,65 % | ||
| KOBAYASHI PHARMACEUTICAL | 1 | 7 | -0,57 % | ||
| ASICS | 1 | 4 | +0,32 % | ||
| NISSHINBO HOLDINGS | 1 | 1 | -0,79 % | ||
| BLOOMZ | - | 6 | -9,20 % | ||
| HEARTCORE ENTERPRISES | - | 4 | +2,57 % | ||
| CAPCOM | - | 3 | +1,48 % | ||
| MEDIROM HEALTHCARE TECHNOLOGIES | - | 2 | +3,15 % | ||
| SYLA TECHNOLOGIES | - | 2 | +2,81 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01:00 | LuxCreo Expands Partnership with ASICS to Make Personalized Shoes Accessible to Everyone | 194 | Business Wire | LuxCreo today announced an expansion of its partnership with ASICS to enable rapid local delivery of personalized 3D printed shoes and insoles that are accessible to everyone.
This press release... ► Artikel lesen | |
| Fr | Apollo pumps $700m into Sony Music Group partnership. (It's a kind of magic!) | 2 | Music Business Worldwide | ||
| Fr | Earnings call: Fujitsu reports robust growth in service solutions | 2 | Investing.com | ||
| Fr | Könnte die PlayStation 5 Pro schon im November kommen? | 2 | TECHBOOK | ||
| Fr | Earnings call: Renesas Electronics posts Q2 results, plans cautious Q3 | 3 | Investing.com | ||
| Fr | EMA Committee's Negative Opinion for Eisai Alzheimer's Drug Focuses on Safety Risks | 3 | MedCity News | ||
| Fr | Toyota plots new EV battery plant to fend off incoming BYD, low-cost Chinese EVs | 33 | Electrek | ||
| Fr | Toyota verlängert | 3 | MotorZeitung.de | ||
| Fr | NTT to develop 500MW data center campus on former Army base outside Frankfurt, Germany - report | 3 | DatacenterDynamics | ||
| Fr | Astellas Pharma Inc.: Astellas Receives Positive CHMP Opinion for Zolbetuximab in Combination with Chemotherapy for Treatment of Advanced Gastric and Gastroesophageal Junction Cancer | 89 | PR Newswire | - If approved by the European Commission, zolbetuximab would become the first and only CLDN18.2-targeted therapy approved in the European Union
- A decision on the EU marketing authorization... ► Artikel lesen | |
| Fr | Astellas Pharma Inc.: Astellas Receives Positive CHMP Opinion for PADCEV (enfortumab vedotin) in combination with KEYTRUDA (pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer | 66 | PR Newswire | - If approved, enfortumab vedotin in combination with pembrolizumab will be the first and only treatment to offer an alternative to platinum-containing chemotherapy, the current standard of care for... ► Artikel lesen | |
| Fr | Nomura's Crypto Unit to Offer Higher-Yielding Ether ETF Alternative | 2 | BNN Bloomberg | ||
| Fr | Research and Markets: Europe Data Center Market Landscape Report 2024-2029 Featuring Major Investors - Digital Realty, Equinix, NTT DATA, atNorth, Iron Mountain, Colt, Orange Business Services, Vantage, STACK - ResearchAndMarkets.com | 418 | Business Wire | The "Europe Data Center Market Landscape 2024-2029" report has been added to ResearchAndMarkets.com's offering.
The Europe Data Center Market was valued at USD 42.98 billion in 2023, and is expected... ► Artikel lesen | |
| Fr | Biogen/Eisai's Alzheimer's Drug Leqembi Gets 'No Go' From European Drug Regulator's Advisory Panel, Cites Serious Side Events | 11 | Benzinga.com | ||
| Fr | No, You Can't Lease A Nissan Leaf For $9. But This Deal Is Still Insane | 3 | InsideEVs | ||
| Fr | Europe's CHMP endorses clutch of new medicines, including Astellas, J&J and Ipsen offerings | 4 | FiercePharma | ||
| Fr | Eisai and Biogen's Alzheimer's med Leqembi turned down in Europe | 6 | FiercePharma | ||
| Fr | Comeback nach 25 Jahren: PlayStation-Meisterwerk macht Fans wieder Hoffnung | 2 | GIGA | ||
| Fr | Private equity giant Apollo invests $700 million in Sony Music | 1 | Channel NewsAsia | ||
| Fr | Kobayashi Pharma Fails to Report Some "Beni Koji" Products | 1 | nippon.com |
Seite:
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
